Skip to main content
Andrew Sloan, MD, Neurosurgery, Atlanta, GA

AndrewSloanMD

Neurosurgery Atlanta, GA

Brain & Spinal Tumor, Neurosurgical Spine Surgery, Pituitary Surgery

Professor & Vice-Chair of Neurological Surgery; Peter D. Cristal Chair of Neurosurgical Oncology; Director, Center for Brain Tumor & Neuro-Oncology; Director, Center of Excellence in Translational Neuro-Oncology; University Hospitals & Seidman Cancer Center Case Comprehensive Cancer Center, & Case Western Reserve University School of Medicine

Dr. Sloan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sloan's full profile

Already have an account?

  • Office

    2001 Peachtree Rd NE
    Ste 645
    Atlanta, GA 30309
    Phone+1 404-605-2050
    Fax+1 216-844-3014

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurological Surgery, 1990 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2022 - 2026
  • MI State Medical License
    MI State Medical License 1998 - 2026
  • CA State Medical License
    CA State Medical License 1992 - 2025
  • FL State Medical License
    FL State Medical License 2004 - 2024
  • OH State Medical License
    OH State Medical License 2006 - 2024
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase I/II study of laser interstitial thermotherapy (LITT) combined with checkpoint inhibitor for recurrent glioblastoma (rGBM). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Immunotherapy Response Linked to Low TMB in Recurrent Glioblastoma
    Immunotherapy Response Linked to Low TMB in Recurrent GlioblastomaJanuary 20th, 2021
  • Medtronic Selects UH Cleveland Medical Center for Stealth Autoguide Precision Robotic Platform for Brain Surgery
    Medtronic Selects UH Cleveland Medical Center for Stealth Autoguide Precision Robotic Platform for Brain SurgeryNovember 11th, 2020
  • Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients with Synchronous Brain Metastases
    Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients with Synchronous Brain MetastasesNovember 28th, 2019
  • Join now to see all

Committees

  • Member, Committee on Appropriateness Criteria, Expert Panel on Musculoskeletal Imaging, American College of Radiology 2015 - Present

Professional Memberships